Literature DB >> 1121995

Retinal vascular lesions in two patients with prolapsed mitral valve leaflets.

H S Woldoff, M Gerber, K B Desser, A Benchimol.   

Abstract

Two patients with retinal vascular lesions had mid-late systolic clicks on cardiac auscultation, suggesting the diagnosis of prolapsed mitral valve. The first patient demonstrated an inferonasal arteriolar branch occlusion secondary to embolization; the second patient had a central vein occlusion with multiple hemorrhages, glial proliferative tissue, and retinal neovascularization. This report describes the association between the prolapsed mitral valve syndrome and retinal vascular lesions.

Entities:  

Mesh:

Year:  1975        PMID: 1121995     DOI: 10.1016/0002-9394(75)90610-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

1.  Visual complications of mitral leaflet prolapse.

Authors:  L A Wilson; P W Keeling; A D Malcolm; R W Russel; M M Webb-Peploe
Journal:  Br Med J       Date:  1977-07-09

2.  Accuracy of visible retinal emboli for the detection of cardioembolic lesions requiring anticoagulation or cardiac surgery. Retinal Emboli of Cardiac Origin Study Group.

Authors:  S Sharma; G C Brown; A F Cruess
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

3.  Randomized trial of therapy with platelet antiaggregants for threatened stroke. 2: Observations on the pathogenesis and natural history of threatened stroke.

Authors:  H J Barnett; M Gent; D L Sackett; D W Taylor
Journal:  Can Med Assoc J       Date:  1980-03-08       Impact factor: 8.262

4.  Embolic retinopathy due to Corynebacterium minutissimum endocarditis.

Authors:  B J Herschorn; A J Brucker
Journal:  Br J Ophthalmol       Date:  1985-01       Impact factor: 4.638

5.  Hemi-central retinal artery occlusion in young adults.

Authors:  Pukhraj Rishi; Ekta Rishi; Tarun Sharma; Sheshadri Mahajan
Journal:  Indian J Ophthalmol       Date:  2010 Sep-Oct       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.